
Pankaj Garg
About Pankaj Garg
Data last updated:
Pankaj Garg is a Managing Director at Medreich Limited (since 2015), Director at Adcock Ingram Limited (since 2016) and Director at Adcock Ingram Pharma Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma and Life Sciences. The 4 current companies with reported revenue have a combined latest revenue of ₹2,250 Cr; the largest is Medreich Limited at ₹1,737 Cr (FY 2024). Earlier, Pankaj Garg was a Company Secretary at Jubilant Chemsys Limited (2011) and Director at Jubilant Innovation (India) Limited (2010–2011) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 31 Jul 2015 | 1973 | ₹1,737 Cr (FY 2024) | Active | |
| Director | 15 Sep 2016 | 2007 | ₹464 Cr (FY 2025) | Active | |
| Director | 07 Jun 2021 | 2021 | ₹47.27 Cr (FY 2025) | Active | |
| Director | 17 Jul 2013 | 2008 | ₹1.83 Cr (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 09 Feb 2011 | 2004 | ₹126 Cr (FY 2019) | Amalgamated | |
| Director | 27 Sep 2010 | 2007 | ₹49,000 (FY 2018) | Dissolved (Liquidated) | |
| Director | 03 May 2012 | 2008 | Under Liquidation |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pankaj Garg
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pankaj Garg
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pankaj Garg
Pankaj Garg currently holds 4 directorships: Medreich Limited (Managing Director, since 31 Jul 2015, revenue ₹1,737 Cr (FY 2024)); Adcock Ingram Limited (Director, since 15 Sep 2016, revenue ₹464 Cr (FY 2025)); Adcock Ingram Pharma Private Limited (Director, since 07 Jun 2021, revenue ₹47.27 Cr (FY 2025)); Medreich Life Care Limited (Director, since 17 Jul 2013, revenue ₹1.83 Cr (FY 2022)).
Pankaj Garg was first appointed on 27 Sep 2010 as Director at Jubilant Innovation (India) Limited. The most recent appointment on record is 07 Jun 2021 at Adcock Ingram Pharma Private Limited.
The 4 current companies of Pankaj Garg that report revenue have a combined latest revenue of ₹2,250 Cr: Medreich Limited ₹1,737 Cr (FY 2024); Adcock Ingram Limited ₹464 Cr (FY 2025); Adcock Ingram Pharma Private Limited ₹47.27 Cr (FY 2025); Medreich Life Care Limited ₹1.83 Cr (FY 2022).
Pankaj Garg held 3 earlier board appointments: Jubilant Chemsys Limited (Company Secretary, 09 Feb 2011 to 28 Sep 2011); Jubilant Innovation (India) Limited (Director, 27 Sep 2010 to 22 Sep 2011); Genovo Development Services Limited (Director, from 03 May 2012).
The current boards of Pankaj Garg's companies include Kenshi Murase (Medreich Limited), Misa Hirose (Medreich Limited), Ramapuram Sreenivasulu Reddy (Medreich Limited), Ryoji Kikuchi (Medreich Limited), Tsutomu Yamada (Medreich Limited), Venkatesh Yandapalli (Medreich Limited), among others.